7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-06-30 2017-03-31 2016-03-31 2015-06-30 2015-03-31 
                                     
      cash flows from operating activities
    		                                 
      net income
    		112,500,000 328,100,000 158,600,000  615,700,000 149,300,000 98,800,000  111,000,000 -62,700,000 125,300,000 158,600,000 282,400,000 248,900,000 594,800,000 660,400,000 547,400,000 946,500,000 890,900,000 554,600,000 332,700,000 204,500,000 -709,000,000 252,000,000  43,200,000 241,200,000 117,700,000 230,500,000 321,900,000 7,900,000 468,100,000 604,800,000 
      adjustments to reconcile net income to net cash flows from operating activities:
    		                                 
      depreciation and amortization
    		48,500,000 47,700,000 46,900,000  46,200,000 45,500,000 45,300,000  48,900,000 44,100,000 44,000,000 44,700,000 42,800,000 40,500,000 19,400,000 11,500,000 13,700,000 13,400,000 13,400,000 13,200,000 12,900,000 13,400,000 12,600,000 16,100,000  12,400,000 11,200,000 10,700,000 10,100,000 10,000,000 17,800,000 28,100,000 39,900,000 
      equity-based compensation
    		90,700,000 92,900,000 103,500,000  121,600,000 125,200,000 108,300,000  64,400,000 68,000,000 54,400,000 14,700,000 54,200,000 45,400,000 39,700,000 41,100,000 42,400,000 47,200,000 32,400,000 26,700,000 18,700,000 30,500,000 29,100,000 36,600,000  49,700,000 64,900,000 84,900,000 88,000,000 72,800,000 75,400,000 114,300,000 89,900,000 
      non-cash performance allocations and incentive fees
    		263,700,000 -265,600,000 15,000,000  -534,100,000 -44,700,000 190,900,000  128,600,000 335,400,000 -36,700,000 209,500,000 273,900,000 211,000,000 -300,800,000 -8,400,000 41,600,000 -838,500,000 -865,400,000 -392,200,000 -268,300,000 -521,800,000 550,500,000 26,300,000    -71,900,000      
      non-cash principal investment income
    		-82,800,000 -40,100,000 72,700,000  -42,800,000 -75,600,000 -70,000,000  -94,300,000 10,400,000 -7,700,000  -118,700,000 -49,800,000 -315,300,000         -134,400,000          
      other non-cash amounts
    		-900,000 24,200,000 12,600,000  17,300,000 1,400,000 -2,900,000  -11,800,000 9,100,000 10,800,000 17,100,000 -15,500,000 -17,200,000 5,300,000 8,400,000 15,200,000 -3,000,000 8,500,000 600,000 7,200,000 -1,200,000 -9,500,000 3,400,000  -1,000,000 -2,200,000 6,900,000 -6,200,000 100,000 -2,300,000 18,000,000 23,800,000 
      consolidated funds related:
    		                                 
      realized/unrealized (gain) loss on investments of consolidated funds
    		-88,500,000 -4,600,000 -7,000,000  24,900,000 -300,000 -82,700,000                 -600,000  10,600,000 26,100,000 15,400,000  -35,200,000    
      realized/unrealized (gain) income from loans payable of consolidated funds
    		-34,700,000 -42,200,000 900,000  -27,400,000 5,400,000 89,700,000                 2,500,000    -17,400,000 -46,300,000 18,100,000 -59,400,000   
      purchases of investments by consolidated funds
    		-4,957,100,000 -1,607,700,000 -2,425,500,000  -1,118,900,000 -2,397,600,000 -1,477,300,000  -602,800,000 -1,331,700,000 -386,600,000 -736,100,000 -1,105,900,000 -958,300,000 -1,025,900,000 -1,542,600,000 -1,164,000,000 -1,774,900,000 -925,500,000 -1,090,900,000 -1,002,700,000 -238,900,000 -807,500,000 -571,800,000  -777,400,000 -1,225,900,000 -911,100,000 -823,400,000 -691,500,000 -320,900,000 -2,097,000,000 -2,139,000,000 
      proceeds from sales and settlements of investments by consolidated funds
    		2,858,200,000 880,300,000 1,430,800,000  1,007,600,000 1,410,800,000 1,276,300,000                           
      non-cash interest income
    		-4,300,000 -4,600,000 -4,100,000  -5,300,000 -4,700,000 -6,700,000  -5,300,000 -12,200,000 -3,700,000 -4,500,000 -3,100,000 -1,800,000 -2,700,000 -2,800,000 -2,300,000 -3,500,000 -3,200,000 -3,500,000 -1,800,000 -1,600,000 -1,200,000 -900,000  -1,100,000 -1,000,000 -900,000 -1,100,000 -1,500,000 -700,000 -14,900,000 -4,000,000 
      change in cash and cash equivalents held at consolidated funds
    		-88,300,000 134,500,000 270,900,000  514,400,000 -621,700,000 -80,000,000  176,700,000 -334,000,000 -20,800,000 -31,500,000 53,400,000 -61,800,000 -21,100,000 -13,200,000 51,800,000 22,600,000 -30,900,000 272,100,000 -280,000,000 73,200,000 -51,400,000 21,700,000  152,100,000 -54,800,000 311,600,000 -29,600,000 375,000,000 277,400,000 356,500,000 778,100,000 
      change in other receivables held at consolidated funds
    		-18,500,000 2,200,000 8,300,000  14,700,000 -22,600,000 -65,000,000  -19,900,000 -17,400,000 7,100,000 3,500,000 5,200,000 16,600,000 -6,000,000 33,000,000 20,800,000 -15,200,000 -84,300,000 14,600,000 48,000,000 -52,100,000 -15,900,000 9,200,000  -15,700,000 53,900,000 -128,700,000 -4,500,000 -23,600,000 -9,000,000 303,300,000 367,200,000 
      change in other liabilities held at consolidated funds
    		79,300,000 -11,500,000 -2,500,000  -410,900,000 302,600,000 227,900,000  -253,300,000 295,400,000 -32,800,000 43,300,000 -348,900,000 2,900,000 -34,100,000 72,200,000 -321,700,000 372,400,000 -7,300,000 71,500,000 262,600,000 -275,500,000 162,300,000 -38,200,000  -218,500,000 -8,700,000 -3,900,000 -137,200,000 -82,100,000 -154,500,000 -702,200,000 208,100,000 
      purchases of investments
    		-106,800,000 -66,000,000 -78,300,000  -33,700,000 -35,000,000 -145,100,000  -94,800,000 -108,000,000 -18,500,000 -70,300,000 -102,800,000 -149,300,000 -307,500,000 -98,700,000 -74,600,000 -39,600,000 -63,800,000 -57,200,000 -49,500,000 -121,900,000 -42,700,000 -109,500,000  -142,900,000 -128,200,000 -100,700,000 -147,500,000 -56,800,000 -22,100,000   
      proceeds from the sale of investments
    		194,400,000 324,800,000 144,800,000  148,200,000 83,000,000 102,100,000  201,200,000 58,600,000 78,600,000 86,600,000 101,200,000 128,800,000 158,300,000 134,600,000 135,600,000 242,200,000 156,000,000 73,900,000 67,400,000 66,400,000 99,800,000 90,600,000  192,100,000 154,600,000 225,200,000 138,100,000 168,800,000    
      payments of contingent consideration
    		-1,700,000 0 -1,000,000  -2,500,000 0 -1,500,000  0 0 -68,600,000 0 0 0 -5,700,000 2,000,000 -100,000 0 -49,900,000  0     0 0 -37,500,000 0 -22,500,000 -75,600,000 -100,000 -3,300,000 
      changes in deferred taxes
    		-51,000,000 12,900,000 -29,400,000  140,800,000 4,600,000 -47,100,000  -11,700,000 -76,500,000 -15,100,000 -70,900,000 -58,200,000 -55,000,000 110,900,000 59,300,000 -32,800,000 221,600,000 260,300,000 129,800,000 66,300,000 39,400,000 -101,000,000 1,300,000  4,000,000 200,000 -2,800,000 3,400,000 -3,100,000 -5,300,000 -800,000 -300,000 
      change in due from affiliates and other receivables
    		7,600,000 -27,000,000 10,700,000  -18,900,000 -27,900,000 6,700,000  21,100,000 -21,300,000 16,900,000 -19,900,000 2,700,000 -55,800,000 -9,500,000 -4,300,000 -6,500,000 -8,100,000 -6,800,000 10,200,000 10,500,000 -29,900,000 11,100,000 27,000,000  46,500,000 -53,400,000 5,100,000 -71,800,000 -2,400,000 3,700,000 -4,500,000 -7,800,000 
      change in deposits and other
    		-500,000 -14,100,000 -10,800,000  2,400,000 11,900,000 -19,700,000  10,500,000 -15,100,000 -33,900,000 1,000,000 -5,700,000 32,700,000 -39,800,000 10,800,000 3,300,000 -25,200,000 -1,400,000 -700,000 3,500,000 -2,700,000 -2,100,000 7,600,000  -5,800,000 0 -12,100,000 -2,600,000 -6,700,000 -1,300,000 -2,100,000 -6,300,000 
      change in accounts payable, accrued expenses and other liabilities
    		-1,300,000 64,500,000 -25,400,000  -21,700,000 -4,400,000 41,500,000  -62,100,000 24,200,000 -63,900,000 13,400,000 39,500,000 -52,900,000 -14,300,000 14,800,000 65,500,000 94,500,000 -69,100,000 53,500,000 -11,000,000 7,500,000 -54,000,000 -20,200,000  114,500,000 39,100,000 -38,300,000 -15,900,000 12,600,000 -24,500,000 48,500,000 -33,100,000 
      change in accrued compensation and benefits
    		54,800,000 211,500,000 -327,700,000  106,600,000 88,200,000 -365,600,000  73,300,000 170,300,000 -371,900,000 129,900,000 106,800,000 208,000,000 -580,100,000 221,700,000 131,200,000 214,100,000 -328,000,000 137,100,000 198,400,000 71,200,000 -196,600,000 122,500,000  141,700,000 74,000,000 -82,900,000 118,700,000 -159,800,000 -143,600,000 -21,300,000 -11,400,000 
      change in due to affiliates
    		1,500,000 17,100,000 6,500,000  1,200,000 100,000 -2,200,000  -400,000 -8,200,000 -200,000 -700,000 -400,000 3,000,000 -200,000 -1,200,000 -23,100,000 24,900,000 -400,000 2,300,000 -3,300,000 7,000,000 -35,200,000 1,500,000  -12,700,000 -11,100,000 -15,500,000 -67,000,000 67,100,000 -22,800,000 675,700,000 12,000,000 
      change in lease right-of-use assets and lease liabilities
    		-3,400,000 -3,500,000 -2,800,000  -1,400,000 -1,800,000 -2,200,000  -2,500,000 -2,200,000 -2,800,000 -1,800,000 -2,400,000 -2,100,000 -2,500,000 -1,400,000 1,300,000 2,000,000 2,600,000 -3,100,000 -800,000 -2,600,000 -3,300,000 -20,000,000          
      change in deferred revenue
    		169,100,000 -222,600,000 280,200,000  247,900,000 -261,400,000 251,600,000  285,000,000 -279,700,000 284,700,000 -270,400,000 287,800,000 -267,400,000 254,500,000 -212,500,000 212,000,000 -220,200,000 255,800,000 -184,100,000 219,500,000 -245,100,000 225,900,000 222,600,000  205,000,000 -166,800,000 147,500,000 -160,300,000 188,000,000 175,200,000 -164,400,000 106,900,000 
      net cash from operating activities
    		-1,559,500,000 -168,800,000 -352,100,000 -352,800,000 791,900,000 -1,269,700,000 71,100,000 254,100,000 799,800,000 -736,500,000 -112,500,000 -120,800,000 300,000,000 -186,800,000 -371,700,000 488,600,000 707,100,000 525,800,000 69,500,000 -58,600,000 -33,700,000 169,000,000 -245,900,000 655,000,000  633,200,000 -515,600,000 -22,600,000 -141,800,000 514,900,000 19,700,000 1,822,000,000 1,475,000,000 
      capital expenditures
    		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 
      free cash flows
    		-1,559,500,000 -168,800,000 -352,100,000 -352,800,000 791,900,000 -1,269,700,000 71,100,000 254,100,000 799,800,000 -736,500,000 -112,500,000 -120,800,000 300,000,000 -186,800,000 -371,700,000 488,600,000 707,100,000 525,800,000 69,500,000 -58,600,000 -33,700,000 169,000,000 -245,900,000 655,000,000  633,200,000 -515,600,000 -22,600,000 -141,800,000 514,900,000 19,700,000 1,822,000,000 1,475,000,000 
      cash flows from investing activities
    		                                 
      purchases of corporate treasury investments
    		    0    -42,100,000 -44,100,000 -101,100,000 0                      
      proceeds from corporate treasury investments
    		        30,000,000 102,300,000 20,100,000                       
      purchases of fixed assets
    		-23,200,000 -17,500,000 -16,700,000  -19,100,000 -17,700,000 -14,200,000  -17,100,000 -19,600,000 -12,900,000 -15,600,000 -7,600,000 -5,100,000 -12,300,000 -14,400,000 -9,400,000 -7,900,000 -9,700,000 -23,900,000 -13,600,000 -10,500,000 -13,200,000 6,200,000  -7,600,000 -7,800,000 -4,700,000 -13,000,000 -3,700,000 -4,200,000 -26,500,000 -17,400,000 
      net cash from investing activities
    		-23,200,000 -17,500,000 -16,700,000 -26,700,000 -14,000,000 -22,700,000 -14,200,000 40,900,000 -29,200,000 38,600,000 -93,900,000 34,400,000 -227,400,000 -5,100,000 -630,700,000 -14,400,000 -6,100,000 -2,000,000 -9,700,000 -23,900,000 -13,600,000 -10,500,000 -13,200,000 6,200,000  -7,600,000 -7,800,000 -4,700,000 52,900,000 -65,800,000 1,500,000 -700,700,000 900,000 
      cash flows from financing activities
    		                                 
      borrowings under credit facilities
    		    0           0    7,000,000 23,300,000 12,800,000 251,000,000           
      repayments under credit facilities
    		    0               -29,300,000 -5,000,000 -259,800,000 -35,800,000           
      issuance of 5.05% senior notes due 2035, net of financing costs
    		                                 
      payments on clo borrowings
    		-11,900,000 -25,500,000 -14,600,000  -37,300,000 -22,100,000 -13,900,000  -2,800,000 -3,400,000 -1,100,000 -7,800,000 100,000 -100,000 -8,900,000                   
      proceeds from clo borrowings, net of financing costs
    		49,700,000 0 15,100,000         18,000,000 14,100,000 300,000 40,800,000                   
      net borrowings on loans payable of consolidated funds
    		1,700,000,000 495,700,000 559,400,000  -108,000,000 1,283,200,000 45,300,000  -98,900,000                      7,600,000   
      dividends to common stockholders
    		-126,500,000 -126,300,000 -126,400,000  -125,500,000 -125,600,000 -126,700,000  -126,300,000 -126,700,000 -118,400,000 -118,200,000 -118,300,000 -117,600,000 -89,500,000 -89,100,000 -89,300,000 -88,700,000 -88,700,000 -88,400,000 -88,300,000 -87,200,000 -87,400,000           
      payment of deferred consideration for carlyle holdings units
    		    0 0 -68,800,000  0 0 -68,800,000 0 0 0 -68,800,000 0 0 0 -68,800,000 0 0 0 -68,800,000           
      contributions from non-controlling interest holders
    		367,800,000 68,300,000 163,000,000  98,800,000 55,700,000 64,700,000  43,500,000 36,800,000 18,700,000 109,100,000 115,200,000 20,100,000 146,800,000 159,000,000 12,800,000 40,700,000 3,700,000 185,800,000 10,200,000 9,800,000 4,200,000 15,600,000  8,700,000 5,500,000 3,400,000   4,300,000 601,600,000 752,200,000 
      distributions to non-controlling interest holders
    		-109,700,000 -34,200,000 -164,200,000  -27,400,000 -26,600,000 -19,000,000  -65,600,000 -24,200,000 -9,900,000 -43,300,000 -16,900,000 -9,500,000 -147,100,000 -18,300,000 -33,400,000 -27,600,000 -15,300,000 -24,300,000 -18,300,000 -10,900,000 -24,300,000 -11,000,000  -20,900,000 -30,700,000 -21,100,000 -15,000,000 -38,000,000 -23,900,000 -1,373,500,000 -1,268,400,000 
      common shares repurchased and net share settlement of equity-based awards
    		-202,700,000 -103,600,000 -176,500,000                               
      change in due to/from affiliates financing activities
    		29,000,000 -44,200,000 40,800,000  2,900,000 -52,400,000 51,700,000  -72,400,000 -84,900,000 74,600,000 -68,000,000 14,500,000 -60,800,000 33,100,000 -90,500,000 9,000,000 -58,300,000 71,100,000 -40,200,000 10,900,000 -21,100,000 51,100,000 32,600,000  -62,500,000 23,200,000 -19,200,000 18,000,000 31,200,000 14,400,000 -500,000 -5,200,000 
      net cash from financing activities
    		2,488,600,000 230,200,000 296,600,000 312,100,000 -346,500,000 933,900,000 -216,700,000 -152,200,000 -355,400,000 544,500,000 -136,500,000 25,900,000 13,000,000 240,400,000 -164,500,000 -400,400,000 88,200,000 220,900,000 -151,200,000 118,200,000 412,100,000 -616,600,000 456,600,000 174,300,000  -261,800,000 357,300,000 54,800,000 54,400,000 -331,400,000 -122,800,000 -976,100,000 -1,607,000,000 
      effect of foreign exchange rate changes
    		43,600,000 33,700,000 5,000,000 -45,000,000 30,400,000 -2,300,000 -4,400,000 27,100,000 -18,700,000 2,200,000 8,300,000 59,500,000 -32,900,000 -29,500,000 -17,400,000 -4,600,000 -500,000 -14,500,000 -11,200,000 15,100,000 15,000,000 8,600,000 -17,000,000 -13,300,000  -2,700,000 -33,400,000 21,700,000 25,200,000 10,600,000 21,300,000 46,100,000 -86,100,000 
      increase in cash, cash equivalents and restricted cash
    		949,500,000           -1,000,000 52,700,000   69,200,000 788,700,000 730,200,000 -102,600,000 50,800,000 379,800,000 -449,500,000 180,500,000 822,200,000  361,100,000 -199,500,000 49,200,000      
      cash, cash equivalents and restricted cash, beginning of period
    		0 0 1,266,500,000  0 0 1,442,100,000  0 0 1,361,500,000 0 0 0 2,475,100,000 0 0 0 989,600,000 0 0 0 828,000,000 0  0 0 1,028,800,000      
      cash, cash equivalents and restricted cash, end of period
    		949,500,000 77,600,000 1,199,300,000  461,800,000 -360,800,000 1,277,900,000  396,500,000 -151,200,000 1,026,900,000 -1,000,000 52,700,000 19,000,000 1,290,800,000 69,200,000 788,700,000 730,200,000 887,000,000 50,800,000 379,800,000 -449,500,000 1,008,500,000 822,200,000  361,100,000 -199,500,000 1,078,000,000      
      supplemental non-cash disclosures
    		                                 
      initial consolidation of consolidated funds
    		0 -2,000,000 57,000,000                             0 36,000,000 
      net asset impact of deconsolidation of consolidated funds
    		-485,900,000               0 0       -11,200,000       -7,167,900,000   
      reconciliation of cash, cash equivalents and restricted cash, end of period:
    		                                 
      cash and cash equivalents
    		945,900,000 85,500,000 1,190,300,000  462,000,000 -361,700,000 1,276,500,000  397,400,000 -139,800,000 1,010,100,000 -1,200,000 53,000,000 18,700,000 1,290,200,000 70,500,000 812,800,000 705,800,000 880,400,000 49,200,000 383,900,000 -453,400,000 1,007,900,000 820,600,000  361,400,000 -191,400,000 1,068,200,000      
      restricted cash
    		3,600,000 -7,900,000 9,000,000  -200,000 900,000 1,400,000  -900,000 -11,400,000 16,800,000 200,000 -300,000 300,000 600,000 -1,300,000 -24,100,000 24,400,000 6,600,000 1,600,000 -4,100,000 3,900,000 600,000 1,600,000  -300,000 -8,100,000 9,800,000      
      total cash, cash equivalents and restricted cash, end of period
    		949,500,000 77,600,000 1,199,300,000  461,800,000 -360,800,000 1,277,900,000  396,500,000 -151,200,000 1,026,900,000 -1,000,000 52,700,000 19,000,000 1,290,800,000 69,200,000 788,700,000 730,200,000 887,000,000 50,800,000 379,800,000 -449,500,000 1,008,500,000 822,200,000  361,100,000 -199,500,000 1,078,000,000      
      cash and cash equivalents held at consolidated funds
    		574,200,000 -107,800,000 570,900,000  -559,000,000 621,500,000 426,000,000  -184,100,000 307,600,000 228,800,000 31,800,000 -53,500,000 61,800,000 168,900,000 13,000,000 -52,700,000 12,900,000 174,600,000 -229,200,000 279,800,000 -72,900,000 170,900,000 -90,200,000  -153,500,000 39,400,000 355,900,000      
      decrease in cash, cash equivalents and restricted cash
    		  -67,200,000  461,800,000 -360,800,000 -164,200,000  396,500,000 -151,200,000 -334,600,000    -1,184,300,000                   
      statements of cash flows data
    		                                 
      net change in cash, cash equivalents and restricted cash
    		                                 
      common shares repurchased and net share settlement of equity awards
    		    -150,500,000 -178,300,000 -150,000,000                           
      proceeds from sale and settlements of investments by consolidated funds
    		        828,700,000 532,600,000 332,500,000 442,000,000 781,400,000 523,300,000 1,113,700,000 1,257,000,000 1,204,800,000 1,352,800,000 1,074,100,000 442,400,000 482,800,000 761,400,000 327,200,000 709,700,000  898,600,000 731,300,000 529,900,000 991,200,000 755,600,000 177,700,000 2,933,500,000 1,992,400,000 
      purchase of abingworth, net of cash acquired
    		           0                      
      purchase of cbam intangibles and investments
    		           0 0 0 -618,400,000                   
      common shares issued for performance allocations
    		           0 2,400,000 5,200,000 31,300,000                   
      common shares repurchased
    		        -42,900,000 -60,500,000 -100,300,000 -38,700,000 -41,600,000 -24,900,000 -80,400,000 -77,300,000 -59,500,000 -15,000,000 -10,000,000 0 0 0 -26,400,000           
      issuance of common shares related to the acquisition of cbam and abingworth
    		           0                      
      realized/unrealized loss on investments of consolidated funds
    		         3,900,000 -145,000,000 88,800,000 71,200,000 204,700,000 43,400,000 23,700,000 2,500,000 -13,500,000 -89,300,000   -550,400,000 932,700,000           
      realized/unrealized loss from loans payable of consolidated funds
    		         -19,500,000 141,400,000 -98,300,000 -40,900,000 -181,200,000 -46,200,000 -16,600,000 -2,400,000 16,100,000 77,000,000   500,100,000 -819,600,000           
      issuance of common shares related to the acquisition of cbam
    		                                 
      net borrowings (payments) on loans payable of consolidated funds
    		          68,700,000  43,500,000    181,100,000 4,100,000 -20,000,000  460,000,000 -258,700,000 393,300,000 -121,400,000  -32,200,000 513,900,000 180,600,000  -330,500,000  -88,000,000 402,200,000 
      right-of-use asset impairment, net of broker fees
    		               0 0                 
      non-cash principal investment loss
    		               -160,200,000 -154,500,000 -127,600,000 -176,200,000   517,200,000 252,100,000           
      other non-cash amounts of consolidated funds
    		                   100,000 100,000 500,000 -200,000           
      purchase of investment in fortitude re
    		                                 
      proceeds from sale of mre, net of cash sold
    		               0 0                 
      proceeds from sale of brazil management entity, net of cash sold
    		               0                  
      issuance of 4.625% subordinated notes due 2061, net of financing costs
    		               0 -100,000                 
      repurchase of 3.875% senior notes due 2023
    		                                 
      change in due to/from affiliates and other receivables of consolidated funds
    		                               11,100,000 -962,200,000 
      supplemental cash disclosures
    		                                 
      cash paid for interest
    		                                 
      cash paid for income taxes
    		                                 
      tax effects from the conversion to a corporation recorded in equity
    		                   -13,800,000 300,000 0 53,600,000           
      issuance of common shares related to the acquisition of cbam intangibles and investments
    		             0 194,500,000                   
      net payments on loans payable of consolidated funds
    		              -21,800,000                   
      issuance of 3.500% senior notes due 2029, net of financing costs
    		                                 
      repayment of term loan
    		                       0          
      proceeds from debt obligations, net of financing costs
    		               24,200,000 -200,000 44,300,000 43,400,000 0    20,500,000          
      payments on debt obligations
    		               -1,000,000 -2,100,000 -162,800,000 -66,600,000 -1,100,000 -1,200,000 -1,200,000 -300,000 -31,300,000  -136,000,000 -7,000,000 -6,800,000      
      redemption of preferred units
    		                                 
      distributions to preferred unitholders
    		                       -5,900,000  -5,900,000 -5,900,000 -5,900,000      
      distributions to non-controlling interest holders in carlyle holdings
    		                       -99,100,000  -51,300,000 -62,900,000 -77,500,000 -24,200,000 -38,900,000 -85,100,000 -81,900,000 -403,600,000 
      common shares issued for carry distributed in shares program
    		                                 
      net increase in partners’ capital and accumulated other comprehensive income related to reallocation of ownership interest in carlyle holdings
    		                       31,700,000  20,900,000 -700,000 -300,000 5,900,000 1,000,000 700,000 10,400,000 9,200,000 
      net decrease to partners’ capital from deferred consideration for carlyle holdings units, net of tax
    		                                 
      non-cash distributions to non-controlling interest holders
    		                       0          
      tax effect from acquisition of carlyle holdings partnership units:
    		                                 
      deferred tax asset
    		                       4,600,000  6,200,000 2,700,000 1,900,000   -200,000   
      tax receivable agreement liability
    		                       4,000,000  5,300,000 2,200,000 1,500,000   -200,000   
      total partners’ capital
    		                       600,000  900,000 500,000 400,000      
      acquisitions, net of cash acquired
    		                                 
      issuance of 5.650% senior notes due 2048, net of financing costs
    		                                 
      non-cash principal investment (income) loss
    		                                 
      payment of purchase price adjustment in fortitude re
    		                    0             
      borrowings under credit facility
    		                                 
      repayments under credit facility
    		                                 
      distributions to common unitholders
    		                       -49,900,000  -23,300,000 -27,800,000 -33,200,000 -9,000,000 -13,700,000 -23,600,000 -23,700,000 -110,900,000 
      common units repurchased
    		                       -22,500,000  -36,500,000        
      aum
    		                                 
      46
    		                                 
      non-cash net performance allocations and incentive fees
    		                         -10,300,000        
      realized/unrealized gain from loans payable of consolidated funds
    		                         -7,700,000        
      principal investment income
    		                         -44,100,000 -77,300,000 -53,800,000      
      deconsolidation of claren road
    		                            0 -23,300,000    
      deconsolidation of urbplan
    		                                 
      change in receivables and inventory of a real estate vie
    		                                 
      change in other assets of a real estate vie
    		                                 
      change in other liabilities of a real estate vie
    		                                 
      proceeds from issuance of preferred units, net of offering costs and expenses
    		                                 
      proceeds from debt obligations
    		                         6,300,000 0 34,500,000 46,000,000 66,100,000    
      net payments on loans payable of a real estate vie
    		                                 
      depreciation, amortization, and impairment
    		                                 
      excess tax benefits related to equity-based compensation
    		                              700,000 -1,000,000 -500,000 
      non-cash performance fees
    		                            -163,000,000 -348,800,000 -7,400,000 320,800,000 -275,700,000 
      realized/unrealized gain on investments of consolidated funds
    		                              67,800,000 -498,500,000 -576,400,000 
      non-cash interest (income) loss
    		                                 
      investment income
    		                               -8,000,000 -3,700,000 
      deconsolidation of esg
    		                                 
      change in restricted cash
    		                            65,900,000 -62,100,000 5,700,000 -674,200,000 18,300,000 
      net proceeds from issuance of common units, net of offering costs
    		                                 
      acquisition of non-controlling interests in carlyle holdings
    		                                 
      increase in cash and cash equivalents
    		                            -9,300,000 128,300,000  191,300,000 -217,200,000 
      cash and cash equivalents, beginning of period
    		                            0 670,900,000 991,500,000 0 1,242,000,000 
      cash and cash equivalents, end of period
    		                            -9,300,000 799,200,000 911,200,000 191,300,000 1,024,800,000 
      increase in partners’ capital related to reallocation of ownership interest in carlyle holdings
    		                                 
      non-cash contributions from non-controlling interest holders
    		                                 
      deferred tax liability
    		                                 
      change in receivables and inventory of a consolidated real estate vie
    		                            13,400,000 -27,900,000 -21,900,000 -7,200,000 -34,400,000 
      change in other assets of a consolidated real estate vie
    		                            3,300,000 -1,700,000 8,600,000 -38,300,000 15,800,000 
      change in other liabilities of a consolidated real estate vie
    		                            -8,700,000 56,600,000 6,200,000 17,100,000 31,900,000 
      net payments on loans payable of a consolidated real estate vie
    		                            -6,900,000 -7,400,000 -9,400,000 -21,600,000 -11,100,000 
      net (payments) borrowings on loans payable of consolidated funds
    		                                 
      units repurchased
    		                            0 -200,000 -6,100,000   
      investment (income) loss
    		                             -44,800,000 10,300,000   
      proceeds from the sale of investments and trading securities
    		                              62,300,000 59,100,000 271,400,000 
      decrease in cash and cash equivalents
    		                              -80,300,000   
      realized/unrealized income from loans payable of consolidated funds
    		                               54,300,000 48,800,000 
      purchases of investments and trading securities
    		                               -15,000,000 -20,100,000 
      issuance of 5.625% senior notes due 2043, net of financing costs
    		                                 
      deconsolidation of consolidated funds
    		                                 
      amortization of deferred financing fees
    		                                 
      purchases of trading securities
    		                                 
      proceeds from sale of trading securities
    		                                 
      purchases of intangible assets
    		                                 
      issuance of 3.875% senior notes due 2023, net of financing costs
    		                                 
      payments on loans payable
    		                                 
      net payment on loans payable of consolidated funds
    		                                 
      net proceeds from issuance of common units in initial public offering
    		                                 
      contributions from predecessor owners
    		                                 
      distributions to predecessor owners
    		                                 
      acquisition of non-controlling interests in consolidated entities
    		                                 
      increase in partners’ capital related to reallocation of ownership interest in carylyle holdings
    		                                 
      increase to partners’ capital from acquisition of non-controlling interests in consolidated entities
    		                                 
      net assets related to consolidation of the clos
    		                                 
      non-cash distributions to predecessor owners
    		                                 
      reorganization:
    		                                 
      transfer of partners’ capital to non-controlling interests in consolidated entities
    		                                 
      deferred taxes from transfer of ownership interests
    		                                 
      exchange of calpers equity interests:
    		                                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.